Publication | Open Access

Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats

BiochemistryMedicineDiabetesPhysiologyStreptozotocin-diabetic RatsDiabetic NeuropathyExperimental PharmacologyPharmacotherapyDiabetes MellitusPeripheral Nerve DisordersPharmacologyOxidative Stress